Alzheimer’s and Parkinson’s diseases predict different COVID-19 outcomes, a UK Biobank study
View ORCID ProfileYizhou Yu, View ORCID ProfileMarco Travaglio, View ORCID ProfileRebeka Popovic, View ORCID ProfileNuno Santos Leal, View ORCID ProfileL. Miguel Martins
doi: https://doi.org/10.1101/2020.11.05.20226605
Yizhou Yu
MRC Toxicology Unit, University of Cambridge
Marco Travaglio
MRC Toxicology Unit, University of Cambridge
Rebeka Popovic
MRC Toxicology Unit, University of Cambridge
Nuno Santos Leal
MRC Toxicology Unit, University of Cambridge
L. Miguel Martins
MRC Toxicology Unit, University of Cambridge
Posted November 07, 2020.
Alzheimer’s and Parkinson’s diseases predict different COVID-19 outcomes, a UK Biobank study
Yizhou Yu, Marco Travaglio, Rebeka Popovic, Nuno Santos Leal, L. Miguel Martins
medRxiv 2020.11.05.20226605; doi: https://doi.org/10.1101/2020.11.05.20226605
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)